Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Cardio Pharmacology > Flashcards

Cardio Pharmacology Flashcards

1
Q

Nifedipine

A

Calcium channel antagonist, DHP. Binds while L-type channel is resting, most peripheral smooth muscle (vasodilation) where channels are more frequently resting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amlodipine

A

Calcium channel antagonist, DHP. Binds while L-type channel is resting, most peripheral smooth muscle (vasodilation) where channels are more frequently resting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diltiazem

A

Calcium channel antagonist, Non-DHP. Binds to L-type channel when OPEN - most effective in cardiac myocytes (which frequently depolarize). Decrease cardiac contractility. Induce Coronary Vasodilation. Lowers automaticity in SA/AV nodes (Reduces HR).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Verapamil

A

Calcium channel antagonist, Non-DHP. Binds to L-type channel when OPEN - most effective in cardiac myocytes (which frequently depolarize). Decrease cardiac contractility. Induce Coronary Vasodilation. Lowers automaticity in SA/AV nodes (Reduces HR).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Furosemide

A

Loop diuretic. Binds Na/K/Cl transporter in Ascending tubule,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HCTZ (hydrochorthiazide)

A

Thiazide diuretic. Acutely Acts on distal tubule, fluid excretion, Na+ excretion, lower blood volume, less BP. Chronically - NO release, vasodilation, decreased PVR - so, volume recovers but BP stays low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Losartan

A

ARB (angiotensin receptor blocker). Blocks AT1 receptor for A-II. Blocks TGF-B1 activation. Downside: DoesnÕt stop cleavage of bradykinin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Enlalapril

A

ACEi. Blocks conversion of A-I to A-II, which prevents downstream actions of A-II. Also blocks cleavage of bradykinin, so it can go on to do great things (NO release).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Direct Renin Inhibitors

A

Éinhibits renin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phenoxybenzamine

A

Non-selective alpha blocker. Vasodilation, decreased PVR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prazosin

A

Selective alpha blocker. Alpha 1 and 2. Vasodilation, decreased PVR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Doxazosin/Terazosin

A

Selective alpha blocker, Alpha 1 only. Vasodilation, decreased PVR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clonidine

A

Central alpha agonist, alpha 2. Stimulate pre-gang alpha-2 receptors in medulla, reduction of sympathetic outflow. Unopposed vagal tone. Decreased PVR, HR, CO, BP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Spironolactone

A

Aldosterone antagonist/mineralocorticoid receptor antagonist. Potassium sparing diuretic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hydralazine

A

Arterial vasodilator. Mechanism unknown. Arteriolar dilation, doesn’t affect veins. Mostly renal, periph, splanchnic, and coronary arterties. Decrease BP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sodium nitroprusside

A

Arterial vasodilator. Metabolised by SMCs into NO –> vasodilation, decrease in PVR. Byproduct = cyanide, which is metabolized by RBCs by rhodanase with help of cofactor sodium thiosulfate. Sodium thiosulfate added to solution to prevent cyanide tox. Unstable in sunlight, they wrap it in foil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nitrates

A

Venodilator. Converts to NO in endothelium, gas diffuses to receptors. Activates guanylyl cyclase which forms c-GMP which inactives myosin light-chain kinase É causes SMC relaxation, esp in veins, decreased platelet aggregation. Also GI and bronchial relaxation. Decreases venous blood return, decreases LV cavity size and ejection force, decreases systolic wall stress, myocardial O2 demand. Increases endocardial perfusion. Decreases thrombs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Propranolol

A

Non-selective beta blocker. Reduce heart rate and renin release by inhibiting sympathetic nervous signaling. Antagonize these systems: 1) Alpha1/2 - increase in vasoconstriction 2) Beta1 - acts on SA/AV nodes and causes increase in chronotropy and ionotropy 3) Beta2 - vasodilation of cardiac vessels and bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Metoprolol

A

Selective beta blocker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Carvedilol

A

Special (alpha 1 and non-selective beta blocker) . Blocks myocyte hypertrophy, myocyte injury, increased arrhythmias, vasoconstriction, RAS activation, etc.

21
Q

Epinephrine

A

Inotrope Pressor Vasoactive Drug. Bends alpha 1/2, Beta 1/2/3. Increase in HR, CO and PVR

22
Q

Norepinephrine

A

Inotrope Pressor Vasoactive Drug. Binds alpha 1/2, Beta 1. Decreased HR, CO. Increased PVR and BP. These effects are mediated by alpha1 (which overrides beta1)

23
Q

Dopamine

A

Inotrope Pressor Vasoactive Drug. Low dose: Delta (renal vasodilation), Med: Delta, Beta 1 (increased CO, renal vasodilation), High: Delta, Beta 1, Alpha 1. (Decreased HR, CO and increased PVR)

24
Q

Dobutamine

A

Inotrope Pressor Vasoactive Drug. Beta 1 and Alpha. Decreases afterload and increases inotropy. Chronic infusions can lead to densensitization. Short acting.

25
Q

Isoproterenol

A

Sympathetic Adrenergic Agonist. Beta 1/2. Increases HR, CO, and decreases PVR.

26
Q

Phenylephrine

A

Inotrope Pressor Vasoactive Drug, Alpha 1/2, increases SVR, decreases HR, CO.

27
Q

Milrinone

A

Inotrope Pressor Vasoactive Drug, PDE3 Inhibitor. Inhibits the degradation of cAMP by PDE. This results in 1) an increase in cardiac conractility and 2) a decrease in PVR (venous dilation)

28
Q

Digoxin

A

Digitalis - “cardiac glycoside”. Blocks Na+/K+ ATPase increases intracellular Na+. As a result, Na+/Ca++ brings more Ca++ into cell. *Competes with K+ to bind, extra-cell K+ prevents toxicity, low K+ can lead to toxicity. Increases inotropy without increase in HR. Also acts like a muscarinic agonist – slows SA/AV node conduction, increases ERP, risk of bradycardia. Can cause v-tach due to delayed afterdepolarizations.

29
Q

Atropine

A

Antimuscarinic (Ach receptor antagonist). Blocks parasympathetic action. Increases HR, decreases refractory period, etc.

30
Q

Acetylcholine

A

Muscarinic agonist. Parasympathetic. Very short half-life, not really used.

31
Q

Edrophonium

A

Ach-esterase inhibitor. Strong parasympathetic discharge.

32
Q

Physostigmine

A

Ach-esterase inhibitor. Strong parasympathetic discharge. Longer acting than edrophonium.

33
Q

Neostigmine

A

Ach-esterase inhibitor. Strong parasympathetic discharge. Longer acting than edrophonium.

34
Q

Anything-astatin

A

Statins - HMG CoA reductaste inhibitor. Increases LDL uptake instead of synthesizing endogenous cholesterol. LDL receptors are up-regulated, and clearance increases. (cholesterol level in liver may be almost normal, but elevated clearance reduces plasma LDLs).

35
Q

Fibrates

A

Fibric acid derivative. Activate nuclear receptor PPAR alpha in liver and periph tissue .. Decreases LDL production, increases VLDL clearance, increases HDLs, decrease TGs.

36
Q

Niacin

A

Vitamin B3 at high doses – reduces FFA release and flux to liver. Increases HDLs, decrease TG, decrease LDL, decrease Lp(a). Adverse: flushing, hepatotoxicityÉ lots of bad crap.

37
Q

Cholesterol absorption inhibitor

A

Éinhibits cholesterol absorption. Acts at brush border, binds and inhibits NPC1L1 cholesterol transporter. Reduces hepatic cholesterol stores, LDL receptor up-regulates, increased clearance.

38
Q

Bile acid sequestrant

A

Bile acid sequestrant. high MW, binds to bile acids and prevents re-absorption.

39
Q

Aspirin

A

Binds Cox 1/2, inhibits. Inhibits platelet aggregation.

40
Q

Clopidogrel

A

Binds P2Y12 receptor. Platelet ADP inhibitor, prevents platelet activation.

41
Q

Glycoprotein Iib/IIIa inhibitor

A

Binds Glycoprotein Iib/IIIa, blocks fibrinogen mediated platelet binding and crosslinking.

42
Q

t-PA, streptokinase, urokinase

A

Thrombolytic drugs. Binds plasminogen. Increase conversion of plasminogen to plasmin, accelerates clot breakdown.

43
Q

Heparin

A

Anticoagulant. Blocks factor Xa and thrombin.

44
Q

Procainamide/Quinidine

A

Class IA Na channel blocker, and inward rect. K+. Affects fast response tissues. Elongates AP. More potent in cells with depol RMP. Strongest.

45
Q

Lidocaine

A

Class IB Na channel blocker, affects fast response tissue, elongates AP, more potent in cells with depol RMP. Weakest.

46
Q

Flecainide

A

Class IC Na channel blocker, affects fast response tissue, elongates AP, more potent in cells with depol RMP. Stronger than IB, weaker than IC.

47
Q

Amiodarone

A

Class III K+ channel blocker, has beta blocker effects too. Increase the refractory period. As heart rate or extracellular K decreases, the refractory period increases. Effective in controlling fast reponse tissues.

48
Q

Sotalol

A

Class III K+ channel blocker, has beta blocker effects too. Increase the refractory period. As heart rate or extracellular K decreases, the refractory period increases. Effective in controlling fast reponse tissues.

49
Q

Adenosine

A

Local metabolite. Binds A1 receptor. 1) Reduces cAMP in cardiac tissue, allowing K to hyperpolarize cells resulting in a greater ERP. 2) Vasodilation of VSMCs

Pharmacology (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions